{"id":1013842,"date":"2026-10-27T06:07:24","date_gmt":"2026-10-27T10:07:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/"},"modified":"2026-10-27T06:07:24","modified_gmt":"2026-10-27T10:07:24","slug":"nautilus-biotechnology-reports-third-quarter-2026-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/","title":{"rendered":"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SEATTLE, Oct.  27, 2026  (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2026.<\/p>\n<p align=\"justify\">\n        <strong>Third Quarter 2026 Business Highlights<\/strong>\n      <\/p>\n<ul>\n<li style=\"text-align:justify\">Published a peer-reviewed paper in Nature Methods showing how Iterative Mapping reveals the proteoforms underlying biology and disease, with potential to yield new biomarkers and drug targets.<\/li>\n<li style=\"text-align:justify\">Shared first development data on oncology proteoform assays, including AKT1, at World HUPO 2026, showing a performance profile matching Tau and supporting platform extensibility.<\/li>\n<li style=\"text-align:justify\">Advanced\u00a0the proteoform pipeline needed to deliver twenty assays planned through mid-2028.<\/li>\n<li style=\"text-align:justify\">Subsequent to quarter end, announced participation in SEEDS, a four-year, multi-center research consortium funded by ARPA-H, with Nautilus expecting to receive up to $6 million to deploy its Voyager Platform<sup>TM<\/sup> to measure proteoforms driving Alzheimer\u2019s disease and cancer.<\/li>\n<\/ul>\n<p align=\"justify\">\u201cThe third quarter marked an important step in demonstrating the power and scalability of Iterative Mapping on our Voyager platform,\u201d said Sujal Patel, CEO of Nautilus Biotechnology. \u201cOur seminal publication in Nature Methods highlights the unique biological insights that our technology can deliver. In addition, our proteoform expansion initiative is on-track, with early oncology assay results that demonstrate the performance we established with Tau is repeatable across additional targets. This repeatability is fundamental to our strategy of building a broad portfolio of proteoform assays, and the progress we are seeing reinforces our confidence in our technology, our development roadmap, and our planned instrument availability in the middle of 2027.\u201d<\/p>\n<p align=\"justify\">\n        <strong>Third Quarter 2026 Financial Results<\/strong>\n      <\/p>\n<p align=\"justify\">Revenue was $0.2 million for the third quarter of 2026, primarily driven by grant revenue from the Company\u2019s activities related to the grant awarded from The Michael J. Fox Foundation during the period, and service revenue for the sales of services under the Iterative Mapping Early Access Program.<\/p>\n<p align=\"justify\">Operating expenses were $16.9 million for the third quarter of 2026, a $1.5 million or 10% increase compared to $15.5 million for the corresponding prior year period. The increase in operating expenses is attributable to higher laboratory and professional services and higher salaries and related benefits expense, partially offset by lower facilities expenses.<\/p>\n<p align=\"justify\">Net loss was $15.6 million for the third quarter of 2026, as compared to the net loss of $13.6 million for the corresponding prior year period.<\/p>\n<p align=\"justify\">Cash, cash equivalents, and investments were $114.3 million as of September 30, 2026.<\/p>\n<p align=\"justify\">\n        <strong>Webcast and Conference Call Information<\/strong>\n      <\/p>\n<p align=\"justify\">Nautilus will host a conference call to discuss the third quarter 2026 financial results, business developments and outlook before market open on Tuesday, October 27, 2026, at 5:30 AM Pacific Time \/ 8:30 AM Eastern Time. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: <u>www.nautilus.bio<\/u>.<\/p>\n<p align=\"left\">\n        <strong>About Nautilus Biotechnology, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus\u2019 mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio<\/p>\n<p align=\"justify\">\n        <strong>Special Note Regarding Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains forward-looking statements within the meaning of federal securities laws. Forward-looking statements in this press release include, but are not limited to, statements regarding Nautilus\u2019 expectations regarding the company\u2019s business operations, financial performance and results of operations; expectations regarding operating expenses and cash runway, including any impact thereon from our reallocation of resources; expectations with respect to any revenue timing or projections; expectations with respect to the development required for and the timing of the launch of the Nautilus Voyager<sup>TM<\/sup> platform, our proteoform applications roadmap and full commercial availability of our proteoform and\/or broadscale products and\/or services; the functionality and performance of the Nautilus Voyager platform, its potential impact on providing proteome or proteoform access, pharmaceutical development and drug discovery, expanding research horizons, and enabling scientific explorations and discovery; expectations regarding platform specifications required by potential customers and partners and the timeline for adoption of the Nautilus Voyager platform by researchers; and the present and future capabilities and limitations of emerging proteomics technologies. These statements are based on numerous assumptions concerning the development of Nautilus\u2019 products, target markets, and other current and emerging proteomics technologies, and involve substantial risks, uncertainties and other factors that may cause actual results to be materially different from the information expressed or implied by these forward-looking statements. Risks and uncertainties that could materially affect the accuracy of Nautilus\u2019 assumptions and its ability to achieve the forward-looking statements set forth in this press release include (without limitation) the following: the Nautilus Voyager product platform is not yet commercially available and remains subject to significant scientific and technical development, which is inherently challenging and difficult to predict, particularly with respect to highly novel and complex products such as those being developed by Nautilus. Even if our development efforts are successful, our product platform will require substantial validation of its functionality and utility in life science research. In the course of Nautilus\u2019 scientific and technical development and associated product validation and commercialization, we may experience material delays as a result of unanticipated events. We cannot provide any guarantee or assurance with respect to the outcome of our development, collaboration, and commercialization initiatives or with respect to their associated timelines, or that we will receive the full amount of the SEEDS funding, which may be reduced, delayed or terminated. For a more detailed description of additional risks and uncertainties facing Nautilus and its development efforts, investors should refer to the information under the caption \u201cRisk Factors\u201d in our Annual Report on Form 10-K as well as in our Quarterly Report on Form 10-Q to be filed for the quarter ended September 30, 2026 and our other filings with the SEC. The forward-looking statements in this press release are as of the date of this press release. Except as otherwise required by applicable law, Nautilus disclaims any duty to update any forward-looking statements. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.<\/p>\n<p align=\"justify\">\n        <strong>Disclosure Information <\/strong>\n      <\/p>\n<p align=\"justify\">Nautilus uses filings with the Securities and Exchange Commission, its website (www.nautilus.bio), press releases, public conference calls, public webcasts, and its social media accounts as means of disclosing material non-public information and for complying with Regulation FD. Therefore, Nautilus encourages investors, the media, and others interested in Nautilus to review the information it makes public in these locations, as such information could be deemed to be material information.<\/p>\n<p align=\"justify\">\n        <strong>Media Contact <\/strong>press@nautilus.bio<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact <\/strong>investorrelations@nautilus.bio<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"8\" style=\"max-width:63%;min-width:63%\">\n            <strong>Nautilus Biotechnology, Inc. <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"8\" style=\"max-width:63%;min-width:63%\">\n            <strong>Condensed Consolidated Balance Sheets <br \/><\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"8\" style=\"max-width:63%;min-width:63%\">\n            <strong>As of September 30, 2026 and December 31, 2025 (Unaudited)<br \/><\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td colspan=\"3\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"3\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td>\n            <em>(in thousands)<\/em>\n          <\/td>\n<td colspan=\"3\" style=\"text-align: center;vertical-align: middle;border-bottom: solid black 1pt\">\n            <strong>September 30, 2026<\/strong>\n          <\/td>\n<td style=\"text-align: center;vertical-align: middle\">\u00a0<\/td>\n<td colspan=\"3\" style=\"text-align: center;vertical-align: middle;border-bottom: solid black 1pt\">\n            <strong>December 31, 2025<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:63%;width:63%;min-width:63%\">\n            <strong>Assets<\/strong>\n          <\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td style=\"max-width:16%;width:16%;min-width:16%\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td style=\"max-width:16%;width:16%;min-width:16%\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Current assets:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Cash and cash equivalents<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">$<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: right;vertical-align: middle;vertical-align: top\">10,467<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>$<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">12,388<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Short-term investments<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: right;vertical-align: middle;vertical-align: top\">76,109<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">91,018<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Prepaid expenses and other current assets<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">3,661<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">2,557<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total current assets<\/td>\n<td style=\"border-top: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">90,237<\/td>\n<td style=\"border-top: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">105,963<\/td>\n<td style=\"border-top: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Property and equipment, net<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">5,268<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">3,457<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Operating lease right-of-use assets<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: right;vertical-align: middle;vertical-align: top\">24,592<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">27,773<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Long-term investments<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: right;vertical-align: middle;vertical-align: top\">27,767<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">52,739<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Other long-term assets<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">1,060<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">1,180<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total assets<\/td>\n<td style=\"text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">$ <\/td>\n<td style=\"text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">148,924<\/td>\n<td style=\"text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-bottom: double black 3pt\">$ <\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">191,112<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>Liabilities and Stockholders\u2019 Equity<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Current liabilities:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Accounts payable<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">$<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,265<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>$<\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">943<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Accrued expenses and other liabilities<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">4,359<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">3,177<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Current portion of operating lease liabilities<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">4,134<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">3,832<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total current liabilities<\/td>\n<td style=\"border-top: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">9,758<\/td>\n<td style=\"border-top: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">7,952<\/td>\n<td style=\"border-top: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Operating lease liabilities, net of current portion<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">22,607<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">26,187<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total liabilities<\/td>\n<td style=\"border-top: solid black 1pt;border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">32,365<\/td>\n<td style=\"border-top: solid black 1pt;border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">34,139<\/td>\n<td style=\"border-top: solid black 1pt;border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Stockholders\u2019 equity:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Preferred stock<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: top\">\u2014<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\u2014<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Common stock<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: top\">13<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">13<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Additional paid-in capital<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">493,940<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">488,737<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Accumulated other comprehensive income (loss)<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 25.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(572<\/td>\n<td>)<\/td>\n<td>\u00a0<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">243<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Accumulated deficit<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(376,822<\/td>\n<td>)<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(332,020<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total stockholders\u2019 equity<\/td>\n<td style=\"border-top: solid black 1pt;border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">116,559<\/td>\n<td style=\"border-top: solid black 1pt;border-bottom: solid black 1pt\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">156,973<\/td>\n<td style=\"border-top: solid black 1pt;border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total liabilities and stockholders\u2019 equity<\/td>\n<td style=\"border-top: solid black 1pt;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">$ <\/td>\n<td style=\"border-top: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">148,924<\/td>\n<td style=\"border-bottom: double black 3pt\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<td style=\"border-top: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">$<\/td>\n<td style=\"border-top: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">191,112<\/td>\n<td style=\"border-top: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"left\">\n        <strong><br \/>\n          <br \/>\n        <\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"16\">\n            <strong>Nautilus Biotechnology, Inc.\u00a0<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"16\">\n            <strong>Condensed Consolidated Statements of Operations <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"16\">\n            <strong>Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"16\" style=\"width:99.8208%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;text-align: left;vertical-align: middle\">\u00a0<\/td>\n<td colspan=\"7\" style=\"width:29.0323%;text-align: center;vertical-align: middle;border-bottom: solid black 1pt\">\n            <strong>\u00a0Three Months Ended September 30,\u00a0<br \/><\/strong>\n          <\/td>\n<td style=\"width:0.985663%\">\u00a0<\/td>\n<td colspan=\"7\" style=\"width:29.1219%;text-align: center;vertical-align: middle;border-bottom: solid black 1pt\">\n            <strong>Nine Months Ended September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <em>(in thousands, except share and per share data)<\/em>\n          <\/td>\n<td colspan=\"3\" style=\"width:13.9785%;text-align: center;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2026<\/strong><br \/>\n            <strong><br \/>\n              <br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:0.985663%;text-align: center;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"3\" style=\"width:14.0681%;text-align: center;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2025<\/strong><br \/>\n            <strong><br \/>\n              <br \/>\n            <\/strong>\n          <\/td>\n<td style=\"width:0.985663%;text-align: center;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"3\" style=\"width:14.0681%;text-align: center;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td style=\"width:0.985663%;text-align: center;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:13.0824%;text-align: center;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: top\">Revenue:<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:12.9032%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:12.9032%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:41%;width:40.681%;min-width:41%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Grant revenue<\/td>\n<td style=\"max-width:1%;width:1.07527%;min-width:1%;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:12%;width:11.9176%;min-width:12%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">208<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1.16487%;min-width:1%;text-align: left;vertical-align: middle;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:12%;width:11.9176%;min-width:12%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u2014<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1.16487%;min-width:1%;text-align: left;vertical-align: middle;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:12%;width:11.9176%;min-width:12%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">388<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1.16487%;min-width:1%;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:12%;width:11.9176%;min-width:12%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">\u2014<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Service revenue<\/td>\n<td style=\"width:1.07527%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">26<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u2014<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">36<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u2014<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total revenue<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">234<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u2014<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">424<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">\u2014<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: top\">Cost of revenue:<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:12.9032%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Cost of service revenue<\/td>\n<td style=\"width:1.07527%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">24<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u2014<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">39<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u2014<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total cost of revenue<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">24<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u2014<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">39<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">\u2014<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: top\">\u00a0<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:12.9032%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: top\">Operating expenses:<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:12.9032%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Research and development<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">10,176<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">9,605<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">29,496<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">31,535<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Selling, general and administrative<\/td>\n<td style=\"width:1.07527%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">6,771<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">5,867<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">19,513<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">19,878<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total operating expenses<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">16,947<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">15,472<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">49,009<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">51,413<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: top\">Other income (expense):<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:12.9032%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Interest income<\/td>\n<td style=\"width:1.07527%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">1,173<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">1,903<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;vertical-align: bottom\">3,922<\/td>\n<td style=\"width:0.985663%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">6,214<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Other expense<\/td>\n<td style=\"width:1.07527%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 15.0px;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">(72<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 20.0px;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">(5<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">(100<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">(21<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Total other income<\/td>\n<td style=\"width:1.07527%;border-bottom: solid black 1pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">1,101<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">1,898<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">3,822<\/td>\n<td style=\"width:0.985663%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">6,193<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:38%;width:40.681%;min-width:38%;vertical-align: top\">Net loss<\/td>\n<td style=\"max-width:1%;width:1.07527%;min-width:1%;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:12%;width:11.9176%;min-width:12%;vertical-align: middle;text-align: left;padding-left: 25.0px;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">(15,636<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;border-bottom: double black 3pt;vertical-align: bottom\">)<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1.16487%;min-width:1%;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:12%;width:11.9176%;min-width:12%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">(13,574<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;border-bottom: double black 3pt;vertical-align: bottom\">)<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1.16487%;min-width:1%;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:12%;width:11.9176%;min-width:12%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">(44,802<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;border-bottom: double black 3pt;vertical-align: bottom\">)<\/td>\n<td style=\"max-width:3%;width:0.985663%;min-width:3%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:1.16487%;min-width:1%;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"max-width:12%;width:11.9176%;min-width:12%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">(45,220<\/td>\n<td style=\"max-width:1%;width:0.985663%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: top\">Net loss per share attributable to common\u00a0stockholders, basic and diluted<\/td>\n<td style=\"width:1.07527%;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">(0.12<\/td>\n<td style=\"width:0.985663%;border-bottom: double black 3pt;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:11.9176%;vertical-align: middle;text-align: left;padding-left: 30.0px;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">(0.11<\/td>\n<td style=\"width:0.985663%;border-bottom: double black 3pt;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">(0.35<\/td>\n<td style=\"width:0.985663%;border-bottom: double black 3pt;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.985663%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">(0.36<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:40.681%;vertical-align: top\">Weighted-average shares used in computing net loss per share attributable to common\u00a0stockholders, basic and diluted<\/td>\n<td style=\"width:1.07527%;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">127,238,065<\/td>\n<td style=\"width:0.985663%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;padding-left: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">126,305,122<\/td>\n<td style=\"width:0.985663%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">127,005,067<\/td>\n<td style=\"width:0.985663%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.985663%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:1.16487%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:11.9176%;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">126,218,587<\/td>\n<td style=\"width:0.985663%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"left\">\n        <strong><br \/>\n          <br \/>\n        <\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"width:62.9902%\">\n            <strong>Nautilus Biotechnology, Inc.\u00a0<\/strong>\n          <\/td>\n<td colspan=\"7\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%\">\n            <strong>Condensed Consolidated Statements of Cash Flows <\/strong>\n          <\/td>\n<td colspan=\"7\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%\">\n            <strong>Nine Months Ended September 30, 2026 and 2025 (Unaudited)<\/strong>\n          <\/td>\n<td colspan=\"7\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%\">\u00a0<\/td>\n<td colspan=\"7\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%\">\u00a0<\/td>\n<td colspan=\"7\" style=\"width:36.8873%;text-align: center;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>Nine Months Ended September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%\">\n            <em>(in thousands)<\/em>\n          <\/td>\n<td colspan=\"3\" style=\"width:17.9534%;text-align: center;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td style=\"width:0.980392%;text-align: center;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"3\" style=\"width:17.9534%;text-align: center;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:63%;width:62.9902%;min-width:63%\">\n            <strong>Cash flows from operating activities<\/strong>\n          <\/td>\n<td style=\"max-width:1%;width:0.980392%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:16%;width:15.9926%;min-width:16%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:0.980392%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:0.980392%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:0.980392%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:16%;width:15.9926%;min-width:16%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"max-width:1%;width:0.980392%;min-width:1%;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">Net loss<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">$<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 10.0px;text-align: right;vertical-align: middle;vertical-align: bottom\">(44,802<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">$<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(45,220<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">Adjustments to reconcile net loss to net cash used in operating activities<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:16.973%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Stock-based compensation expense<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 25.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">3,812<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">5,373<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Amortization of operating lease right-of-use assets<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 25.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">3,180<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">3,529<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Depreciation<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">884<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">1,348<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Amortization (accretion) of premiums (discounts) on securities, net<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(36<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(1,286<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Changes in operating assets and liabilities:<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:16.973%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:16.973%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Prepaid expenses and other assets<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(982<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">149<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Accounts payable<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">48<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(71<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Accrued expenses and other liabilities<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 25.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">1,066<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">1,332<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 20.0px;vertical-align: top\">Operating lease liabilities<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 20.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(3,277<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(3,475<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 30.0px;vertical-align: top\">Net cash used in operating activities<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 10.0px;padding-right: 0;text-align: right;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">(40,107<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">(38,321<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>Cash flows from investing activities<\/strong>\n          <\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:16.973%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:16.973%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">Proceeds from maturities of securities<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 15.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">76,596<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">74,241<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">Purchases of securities<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 10.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(37,494<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(38,771<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">Purchases of property and equipment<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 20.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(2,409<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(1,033<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 30.0px;vertical-align: top\">Net cash provided by investing activities<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 15.0px;padding-right: 0;text-align: right;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">36,693<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">34,437<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>Cash flows from financing activities<\/strong>\n          <\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:16.973%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:16.973%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">Proceeds from exercise of stock options<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 25.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">1,233<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">26<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">Proceeds from issuance of common stock under employee stock purchase plan<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">142<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">87<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 30.0px;vertical-align: top\">Net cash provided by financing activities<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 25.0px;padding-right: 0;text-align: right;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">1,375<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">113<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-top: solid black 1pt;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;vertical-align: middle;text-align: left;padding-left: 30.0px;vertical-align: top\">Net decrease in cash, cash equivalents and restricted cash<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 20.0px;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(2,039<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: bottom\">(3,771<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: bottom\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:16.973%;text-align: right;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:16.973%;text-align: left;vertical-align: middle;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">Cash, cash equivalents and restricted cash at beginning of period<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 15.0px;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">13,390<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">28,648<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:62.9902%;text-align: left;vertical-align: middle;vertical-align: top\">Cash, cash equivalents and restricted cash at end of period<\/td>\n<td style=\"width:0.980392%;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:15.9926%;vertical-align: middle;text-align: left;padding-left: 15.0px;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">11,351<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;vertical-align: bottom\">\u00a0<\/td>\n<td style=\"width:0.980392%;border-bottom: double black 3pt;vertical-align: bottom\">$<\/td>\n<td style=\"width:15.9926%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">24,877<\/td>\n<td style=\"width:0.980392%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: double black 3pt;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjQ1MTFmODQtOTRjNi00NTg4LWFmNTMtNjNlY2ZiNWVjNjlhLTEyMTk4NjUtMjAyNi0xMC0yNy1lbg==\/tiny\/Nautilus-Biotechnology-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Business Highlights Published a peer-reviewed paper in Nature Methods showing how Iterative Mapping reveals the proteoforms underlying biology and disease, with potential to yield new biomarkers and drug targets. Shared first development data on oncology proteoform assays, including AKT1, at World HUPO 2026, showing a performance profile matching Tau and supporting platform extensibility. Advanced\u00a0the proteoform pipeline needed to deliver twenty assays planned through mid-2028. Subsequent to quarter end, announced participation in SEEDS, a four-year, multi-center research consortium funded by ARPA-H, with Nautilus expecting to receive &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Nautilus Biotechnology Reports Third Quarter 2026 Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1013842","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nautilus Biotechnology Reports Third Quarter 2026 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Business Highlights Published a peer-reviewed paper in Nature Methods showing how Iterative Mapping reveals the proteoforms underlying biology and disease, with potential to yield new biomarkers and drug targets. Shared first development data on oncology proteoform assays, including AKT1, at World HUPO 2026, showing a performance profile matching Tau and supporting platform extensibility. Advanced\u00a0the proteoform pipeline needed to deliver twenty assays planned through mid-2028. Subsequent to quarter end, announced participation in SEEDS, a four-year, multi-center research consortium funded by ARPA-H, with Nautilus expecting to receive &hellip; Continue reading &quot;Nautilus Biotechnology Reports Third Quarter 2026 Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-27T10:07:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results\",\"datePublished\":\"2026-10-27T10:07:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/\"},\"wordCount\":1472,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/\",\"name\":\"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=\",\"datePublished\":\"2026-10-27T10:07:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results - Market Newsdesk","og_description":"SEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Business Highlights Published a peer-reviewed paper in Nature Methods showing how Iterative Mapping reveals the proteoforms underlying biology and disease, with potential to yield new biomarkers and drug targets. Shared first development data on oncology proteoform assays, including AKT1, at World HUPO 2026, showing a performance profile matching Tau and supporting platform extensibility. Advanced\u00a0the proteoform pipeline needed to deliver twenty assays planned through mid-2028. Subsequent to quarter end, announced participation in SEEDS, a four-year, multi-center research consortium funded by ARPA-H, with Nautilus expecting to receive &hellip; Continue reading \"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-27T10:07:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results","datePublished":"2026-10-27T10:07:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/"},"wordCount":1472,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/","name":"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=","datePublished":"2026-10-27T10:07:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1Mzc1MCM3OTE2NjY1IzIyMDgzMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-reports-third-quarter-2026-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nautilus Biotechnology Reports Third Quarter 2026 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1013842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1013842"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1013842\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1013842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1013842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1013842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}